Showing results (131-140 of 690) with videos related to
Sort By:
Pageof 69
Journal of Neurology|March 25, 2022
MRI predictors for the conversion from contrast-enhancing to iron rim multiple sclerosis lesionsNicolas Wenzel, Matthias Wittayer, Claudia E Weber, et al.Magnetic Resonance Imaging|January 11, 2019
Diffusion-weighted imaging of the dentate nucleus after repeated application of gadolinium-based contrast agents in multiple sclerosisPhilipp Eisele, Kristina Szabo, Anne Ebert, et al.Therapeutic Advances in Neurological Disorders|February 17, 2018
Off-label use of IV t-PA in patients with intracranial neoplasm and cavernomaChristopher Jan Schwarzbach, Anne Ebert, Michael G Hennerici, et al.Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|December 3, 2020
Venous Diameter Changes in Chronic Active Multiple Sclerosis LesionsClaudia E Weber, Matthias Kraemer, Andreas Dabringhaus, et al.Magnetic Resonance Imaging|October 21, 2022
Exploring (peri-) lesional and structural connectivity tissue damage through T1/T2-weighted ratio in iron rim multiple sclerosis lesionsMatthias Wittayer, Claudia E Weber, Julia Krämer, et al.Multiple Sclerosis and Related Disorders|July 26, 2020
Investigation of the "central vein sign" in infratentorial multiple sclerosis lesionsClaudia E Weber, Vesile Sandikci, Anne Ebert, et al.Neuro-Oncology|October 15, 2014
Impact of imaging measurements on response assessment in glioblastoma clinical trialsDavid A Reardon, Karla V Ballman, Jan C Buckner, et al.Journal of Neuro-Oncology|July 17, 2016
Impact of tapering and discontinuation of bevacizumab in patients with progressive glioblastomaAnne Hertenstein, Thomas Hielscher, Oliver Menn, et al.Journal of Neuro-Oncology|October 23, 2012
Mibefradil, a novel therapy for glioblastoma multiforme: cell cycle synchronization and interlaced therapy in a murine modelStephen T Keir, Henry S Friedman, David A Reardon, et al.Neuro-Oncology|December 17, 2013
Progression-free survival as a surrogate endpoint for overall survival in glioblastoma: a literature-based meta-analysis from 91 trialsKelong Han, Melanie Ren, Wolfgang Wick, et al.Pageof 69